Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Mind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...

P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

THE cold weather can trigger a range of symptoms, with the most common being shivering. But if certain symptoms seem out of ...

Medically reviewed by Daniel More, MD Cats are one of the most popular household pets, but between 5% and 20% of people have ...

A recent population-based study from South Korea highlights the long-term dermatological complications linked to COVID-19 ...

The billionaire businesswoman-philanthropist was given a new name 'Kamala' by her guru Mahamandaleshwar Swami Kailashanand ...

Leerink Partners analyst Andrew Berens has assigned their neutral stance on BPMC stock, giving a Hold rating on January 13.Stay Ahead of the ...

The billionaire businesswoman-philanthropist was given a new name 'Kamala' by her guru Mahamandaleshwar Swami Kailashanand ...

Wedbush lowered the firm’s price target on Blueprint Medicines (BPMC) to $124 from $135 and keeps an Outperform rating on the shares. The firm ...

Episode 145For the Love of Goats There have been instances where a goat owner watched a severely parasitized, anemic goat die ...

Jasper Therapeutics, Inc. (NASDAQ:JSPR) reported preliminary data from the ongoing BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with chronic spontaneous urticaria (CSU).